Bluejay Diagnostics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Bluejay Diagnostics, Inc. (BJDX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 8.52 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-10
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 15.13M shares, a 380.59% increase year-over-year.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 10.49M shares, a 233.38% increase year-over-year.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 3.15M shares.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 3.15M shares.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 8.52M shares, a 170.79% increase from fiscal 2020.
- Bluejay Diagnostics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 3.15M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 15.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 12.81M shares derived: average of 2 quarters · filed 2022-03-10 | 8.52M shares 10-K · filed 2022-03-10 | |
| 2021-09-30 | 10.49M shares 10-Q · filed 2021-12-16 | 6.32M shares 10-Q · filed 2021-12-16 | ||
| 2020-12-31 | 3.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 3.15M shares derived: average of 2 quarters · filed 2022-03-10 | 3.15M shares 10-K · filed 2022-03-10 | |
| 2020-09-30 | 3.15M shares 10-Q · filed 2021-12-16 | 3.15M shares 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |